Recurrent Bell's palsy

Potential association between recurrent facial nerve palsy and migraines

OBJECTIVE

This study aimed to investigate the possible association between recurrent facial nerve palsy and migraines.

METHOD

This study was a prospective case series with a two-year follow-up at an academic, tertiary referral centre and included patients with at least four episodes of recurrent lower motor neuron facial nerve palsy. All patients underwent standardised diagnostic tests.

RESULTS

Four patients fulfilled the inclusion criteria. The patients were all female with an average age at presentation of 40.75 years (range, 33-60 years) and an average age at the initial episode of 14 years (range, 12-16 years). The number of episodes varied between six and nine. All patients had at least one episode of facial nerve palsy on the contralateral side. Two patients were diagnosed and treated for migraine with aura remaining asymptomatic following prophylactic medication for migraines.

CONCLUSION

The results raise the possibility of an association between recurrent facial nerve palsy and migraines. Prospective studies in patients with even fewer episodes of facial nerve palsy could shed more light on this association.

Immunologic abnormalities and surgical experiences in recurrent facial nerve paralysis

OBJECTIVE

To document immunologic findings in patients with recurrent facial paralysis (RFP) and to compare the results of the surgery with the results of medical treatment.

STUDY DESIGN

Retrospective case review.

SETTING

Tertiary care referral center.

PATIENTS

Nine patients with RFP were reviewed.

INTERVENTION

Patients underwent nonspecific antibody detection, protein electrophoresis (in blood and cerebrospinal fluid [CSF]) and oligoclonal band determination for immunoglobulin G, A, and M (in CSF). The extended subtotal facial nerve decompression via the transmastoid and transattic route was performed in four patients. Five patients received medical treatment only (steroids, vitamin B).

RESULTS

Two patients had the complete and four patients had the oligosymptomatic form of Melkersson-Rosenthal syndrome. The other three patients were diagnosed with idiopathic RFP. Serum immunoglobulin G was high in seven of nine patients (77%). CSF protein electrophoresis demonstrated an elevated albumin fraction in six of nine patients (66%). CSF immunoglobulin G was high in four of nine patients (44%). The oligoclonal band in CSF was negative in all patients. Mean follow-up time was 5.2 +/- 2.6 years and 3 +/- 1.5 years for surgically treated patients and medically treated patients, respectively. None of the patients who underwent the surgery demonstrated recurrence. Although marked recovery was observed in patients who had received medical treatment, three of them had recurrence during the follow-up period.

CONCLUSION

Serologic test results have demonstrated immune system involvement in cases of idiopathic RFP and in cases of Melkersson-Rosenthal syndrome, providing no distinction between the two. There was no sign substantiating local antibody production in CSF, which implies that the elevated antibodies in CSF were peripheral in origin. Although the serologic test results were not conclusive for a specific diagnosis, they support an immune-mediated pathogenesis. Despite the small number of patients who underwent the extended transmastoid facial nerve decompression, our follow-up data were suggestive for the prevention of recurrences.

Paralisia facial periférica idiopática de Bell: a propósito de 180 pacientes

O objetivo deste estudo foi analisar aspectos clínicos, epidemiológicos e evolutivos da paralisia facial periférica idiopática em 180 pacientes. Houve ligeiro predomínio do sexo feminino (66,7%). Quanto à faixa etária mais acometida, foram observados dois picos de incidência um nas terceira e quarta décadas, e o outro na sexta década de vida. Nos 180 pacientes houve 198 episódios de paralisia facial periférica, sendo 17 recorrências e em um paciente a paralisia foi de instalação inicial bilateral. Em 15 pacientes (8,3%) houve recidiva da paralisia facial, em dois casos a paralisia se repetindo por mais duas vezes. Em 12 casos (70,6%) a recidiva ocorreu no mesmo lado da paralisia anterior. O lado esquerdo da face estava envolvido em 55,6% dos casos. Em oito pacientes a paralisia aconteceu na gestação (n=5) ou no pós-parto (n=3). Quatro das pacientes grávidas apresentaram paralisia de Bell no terceiro trimestre. Uma paciente com 18 anos de idade desenvolveu paralisia facial do lado direito no sétimo mês da gravidez, havendo recidiva da paralisia no mesmo lado aos 23 anos de idade, no 15º dia pós-parto. Como condicões associadas encontramos hipertensão arterial sistêmica (11,7%), diabete mélito (11,1%), gravidez ou pós-parto imediato (4,4%; 6,7% nas mulheres) e neurocisticercose (1,1%). Em 72,8% dos casos não encontramos associação com outras afecções. Em 22,8% dos pacientes observou-se uma das seguintes sequelas: espasmo hemifacial (12,8%), recuperação parcial do déficit motor (10,6%), síndrome das lágrimas do crocodilo (3,3%), contrações sincinéticas (2,8%), lacrimejamento (1,1%) e fenômeno de Marcus Gunn invertido (1,1%). Concluíndo, no estudo foi demonstrado que a paralisia facial periférica idiopática pode provocar sequelas importantes, cosméticas ou funcionais, em mais de 20% dos pacientes.

IgG index in acute idiopathic peripheral facial palsy

OBJECTIVES

Etiologic hypotheses in acute idiopathic peripheral facial palsy (AIPFP) mostly point to an immunologic dysfunction, probably virus-induced. Though various immunologic abnormalities are reported, the problem is still unsolved. We investigated intrathecal immunoglobulin synthesis in AIPFP as a clue for central nervous system (CNS) immunopathology.

MATERIAL AND METHODS

We studied IgG index in 24 patients with AIPFP, 10 with other neurological diseases (OND) and 17 with multiple sclerosis (MS). CSF and serum IgG were measured by radial immunodiffusion technique. IgG index is calculated according to Tibbling's formula.

RESULTS

IgG indexes were abnormal in 6 patients with AIPFP, 3 with OND and 10 with MS patients. There was no statistical difference between AIPFP and OND groups, while marked difference existed between AIPFP and MS groups.

CONCLUSION

Though IgG indexes were high in 25% of AIPFP patients, statistical analyses did not show any significance of this finding. Lack of a positive result might reflect non-existence of an extensive immunologic pathology within CNS, excluding a very limited one.